Cargando…

Chylous Ascites: Evaluation and Management

Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Busafi, Said A., Ghali, Peter, Deschênes, Marc, Wong, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890871/
https://www.ncbi.nlm.nih.gov/pubmed/27335837
http://dx.doi.org/10.1155/2014/240473
_version_ 1782435173927747584
author Al-Busafi, Said A.
Ghali, Peter
Deschênes, Marc
Wong, Philip
author_facet Al-Busafi, Said A.
Ghali, Peter
Deschênes, Marc
Wong, Philip
author_sort Al-Busafi, Said A.
collection PubMed
description Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most prevalent in developing countries, whereas congenital abnormalities of the lymphatic system and trauma are commonest in children. The presence of a milky, creamy appearing ascitic fluid with triglyceride content above 200 mg/dL is diagnostic, and, in the majority of cases, unless there is a strong suspicion of malignancy, further investigations are not required in patients with cirrhosis. If an underlying cause is identified, targeted therapy is possible, but most cases will be treated conservatively, with dietary support including high-protein and low-fat diets supplemented with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostatins. Rarely, resistant cases have been treated by transjugular intrahepatic portosystemic shunt, surgical exploration, or peritoneovenous shunt.
format Online
Article
Text
id pubmed-4890871
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48908712016-06-22 Chylous Ascites: Evaluation and Management Al-Busafi, Said A. Ghali, Peter Deschênes, Marc Wong, Philip ISRN Hepatol Review Article Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most prevalent in developing countries, whereas congenital abnormalities of the lymphatic system and trauma are commonest in children. The presence of a milky, creamy appearing ascitic fluid with triglyceride content above 200 mg/dL is diagnostic, and, in the majority of cases, unless there is a strong suspicion of malignancy, further investigations are not required in patients with cirrhosis. If an underlying cause is identified, targeted therapy is possible, but most cases will be treated conservatively, with dietary support including high-protein and low-fat diets supplemented with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostatins. Rarely, resistant cases have been treated by transjugular intrahepatic portosystemic shunt, surgical exploration, or peritoneovenous shunt. Hindawi Publishing Corporation 2014-02-03 /pmc/articles/PMC4890871/ /pubmed/27335837 http://dx.doi.org/10.1155/2014/240473 Text en Copyright © 2014 Said A. Al-Busafi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Al-Busafi, Said A.
Ghali, Peter
Deschênes, Marc
Wong, Philip
Chylous Ascites: Evaluation and Management
title Chylous Ascites: Evaluation and Management
title_full Chylous Ascites: Evaluation and Management
title_fullStr Chylous Ascites: Evaluation and Management
title_full_unstemmed Chylous Ascites: Evaluation and Management
title_short Chylous Ascites: Evaluation and Management
title_sort chylous ascites: evaluation and management
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890871/
https://www.ncbi.nlm.nih.gov/pubmed/27335837
http://dx.doi.org/10.1155/2014/240473
work_keys_str_mv AT albusafisaida chylousascitesevaluationandmanagement
AT ghalipeter chylousascitesevaluationandmanagement
AT deschenesmarc chylousascitesevaluationandmanagement
AT wongphilip chylousascitesevaluationandmanagement